Development of a System for Postmarketing Population Pharmacokinetic and Pharmacodynamic Studies Using Real‐World Data From Electronic Health Records

Postmarketing population pharmacokinetic (PK) and pharmacodynamic (PD) studies can be useful to capture patient characteristics affecting PK or PD in real‐world settings. These studies require longitudinally measured dose, outcomes, and covariates in large numbers of patients; however, prospective data collection is cost‐prohibitive. Electronic health records (EHRs) can be an excellent source for such data, but there are challenges, including accurate ascertainment of drug dose. We developed a standardized system to prepare datasets from EHRs for population PK/PD studies. Our system handles a variety of tasks involving data extraction from clinical text using a natural language processing algorithm, data processing, and data building. Applying this system, we performed a fentanyl population PK analysis, resulting in comparable parameter estimates to a prior study. This new system makes the EHR data extraction and preparation process more efficient and accurate and provides a powerful tool to facilitate postmarketing population PK/PD studies using information available in EHRs.

[1]  Hongfang Liu,et al.  Research and applications: MedXN: an open source medication extraction and normalization tool for clinical text , 2014, J. Am. Medical Informatics Assoc..

[2]  Marylyn D. Ritchie,et al.  PheWAS: demonstrating the feasibility of a phenome-wide scan to discover gene–disease associations , 2010, Bioinform..

[3]  B. Breyer,et al.  Minority Recruitment Trends in Phase III Prostate Cancer Clinical Trials (2003 to 2014): Progress and Critical Areas for Improvement , 2019, The Journal of urology.

[4]  Jon Wakefield,et al.  Population modelling in drug development , 1999, Statistical methods in medical research.

[5]  Paul A. Harris,et al.  PheKB: a catalog and workflow for creating electronic phenotype algorithms for transportability , 2016, J. Am. Medical Informatics Assoc..

[6]  Marylyn D. Ritchie,et al.  The use of a DNA biobank linked to electronic medical records to characterize pharmacogenomic predictors of tacrolimus dose requirement in kidney transplant recipients , 2012, Pharmacogenetics and genomics.

[7]  H. Shimomura,et al.  Population pharmacodynamic analysis of LDL-cholesterol lowering effects by statins and co-medications based on electronic medical records. , 2014, British journal of clinical pharmacology.

[8]  R. Caprioli,et al.  Pragmatic pharmacology: population pharmacokinetic analysis of fentanyl using remnant samples from children after cardiac surgery. , 2016, British journal of clinical pharmacology.

[9]  Shiew-Mei Huang,et al.  Real‐World Data and Clinical Pharmacology: A Regulatory Science Perspective , 2019, Clinical pharmacology and therapeutics.

[10]  P. Kannankeril,et al.  Association Between Perioperative Dexmedetomidine and Arrhythmias After Surgery for Congenital Heart Disease , 2015, Circulation. Arrhythmia and electrophysiology.

[11]  Hongfang Liu,et al.  CLAMP – a toolkit for efficiently building customized clinical natural language processing pipelines , 2017, J. Am. Medical Informatics Assoc..

[12]  Son Doan,et al.  Application of information technology: MedEx: a medication information extraction system for clinical narratives , 2010, J. Am. Medical Informatics Assoc..

[13]  M. Pencina,et al.  Electronic Health Records and Pharmacokinetic Modeling to Assess the Relationship between Ampicillin Exposure and Seizure Risk in Neonates. , 2016, The Journal of pediatrics.

[14]  S. V. Van Driest,et al.  Real‐World Data for Pediatric Pharmacometrics: Can We Upcycle Clinical Data for Research Use? , 2019, Clinical pharmacology and therapeutics.

[15]  J G Linneman,et al.  A genome-wide association study identifies variants in KCNIP4 associated with ACE inhibitor-induced cough , 2015, The Pharmacogenomics Journal.

[16]  D. Roden,et al.  Predicting Clopidogrel Response Using DNA Samples Linked to an Electronic Health Record , 2012, Clinical pharmacology and therapeutics.

[17]  I. James,et al.  HLA-A*32:01 is strongly associated with vancomycin-induced drug reaction with eosinophilia and systemic symptoms. , 2019, The Journal of allergy and clinical immunology.

[18]  M. Cohen-Wolkowiez,et al.  Use of Therapeutic Drug Monitoring, Electronic Health Record Data, and Pharmacokinetic Modeling to Determine the Therapeutic Index of Phenytoin and Lamotrigine , 2016, Therapeutic drug monitoring.

[19]  J. Fisher,et al.  Challenging assumptions about minority participation in US clinical research. , 2011, American journal of public health.

[20]  Nicholas H. G. Holford,et al.  The Population Approach: Rationale, Methods, and Applications in Clinical Pharmacology and Drug Development , 1994 .

[21]  Hannah L Weeks,et al.  medExtractR: A targeted, customizable approach to medication extraction from electronic health records , 2020, J. Am. Medical Informatics Assoc..

[22]  A. Israni,et al.  Dosing equation for tacrolimus using genetic variants and clinical factors. , 2011, British journal of clinical pharmacology.

[23]  Cosmin Adrian Bejan,et al.  A post-processing algorithm for building longitudinal medication dose data from extracted medication information using natural language processing from electronic health records , 2019, bioRxiv.